Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Autologous Tumor-Derived gp96 Heat Shock Protein-Peptide Complex

EU orphan designation number: EU/3/05/270   
Active ingredient: Autologous Tumor-Derived gp96 Heat Shock Protein-Peptide Complex
Indication: Treatment of renal cell carcinoma
Sponsor: Antigenics Therapeutics Limited
25/28 North Wall Quay, Dublin 1, Ireland

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
14/04/2005 Centralised Orphan - Designation EMEA/OD/096/04 (2005)1200 of 11/04/2005